aztreonam has been researched along with Liver Diseases in 4 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
Liver Diseases: Pathological processes of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
"12 L/h/kg), and terminal half-life is 1." | 2.37 | Clinical pharmacokinetics of aztreonam. ( Mattie, H, 1988) |
" Renal insufficiency may significantly impair the elimination of aztreonam, thus requiring modification of the dosage regimen." | 2.37 | Review of the clinical pharmacology of the monobactam antibiotic aztreonam. ( Swabb, EA, 1985) |
"Aztreonam is a monocyclic beta-lactam antibiotic that inhibits aerobic gram-negative bacilli, including beta-lactamase-producing species." | 1.27 | Current state of infectious diseases--potential areas of directed therapy with aztreonam. ( Neu, HC, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iakovlev, VP | 1 |
Khlebnikov, EP | 1 |
VishnevskiÄ, VA | 1 |
Moroz, VIu | 1 |
Popov, SV | 1 |
Elagina, LV | 1 |
Mattie, H | 1 |
Swabb, EA | 1 |
Neu, HC | 1 |
2 reviews available for aztreonam and Liver Diseases
Article | Year |
---|---|
Clinical pharmacokinetics of aztreonam.
Topics: Aging; Aztreonam; Bacterial Infections; Drug Administration Routes; Humans; Kidney; Kidney Diseases; | 1988 |
Review of the clinical pharmacology of the monobactam antibiotic aztreonam.
Topics: Anti-Bacterial Agents; Aztreonam; Child; Drug Administration Schedule; Feces; Gram-Negative Aerobic | 1985 |
1 trial available for aztreonam and Liver Diseases
Article | Year |
---|---|
[Use of aztreonam for the purpose of preventing postoperative purulent complications].
Topics: Aztreonam; Gram-Negative Bacteria; Humans; Liver Diseases; Microbial Sensitivity Tests; Monobactams; | 1996 |
1 other study available for aztreonam and Liver Diseases
Article | Year |
---|---|
Current state of infectious diseases--potential areas of directed therapy with aztreonam.
Topics: Abdomen; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infections; Biliary Trac | 1985 |